Target Price | €74.43 |
Price | €59.60 |
Potential | 24.88% |
Number of Estimates | 17 |
17 Analysts have issued a price target Brenntag 2026 . The average Brenntag target price is €74.43. This is 24.88% higher than the current stock price. The highest price target is €91.00 52.68% , the lowest is €60.00 0.67% . | |
A rating was issued by 18 analysts: 10 Analysts recommend Brenntag to buy, 6 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Brenntag stock has an average upside potential 2026 of 24.88% . Most analysts recommend the Brenntag stock at Purchase. |
16 Analysts have issued a sales forecast Brenntag 2025 . The average Brenntag sales estimate is €17.0b . This is 4.99% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €18.6b 14.56% , the lowest is €16.5b 1.77% .
This results in the following potential growth metrics:
2024 | €16.2b | 3.44% |
---|---|---|
2025 | €17.0b | 4.99% |
2026 | €17.8b | 4.14% |
2027 | €18.4b | 3.56% |
2028 | €17.7b | 3.51% |
2029 | €19.5b | 9.69% |
16 Analysts have issued an Brenntag EBITDA forecast 2025. The average Brenntag EBITDA estimate is €1.6b . This is 24.91% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €1.7b 38.71% , the lowest is €1.5b 19.61% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €1.3b | 10.73% |
---|---|---|
2025 | €1.6b | 21.81% |
2026 | €1.7b | 6.63% |
2027 | €1.8b | 6.11% |
2028 | €1.8b | 3.21% |
2029 | €1.9b | 3.71% |
2024 | 7.94% | 7.55% |
---|---|---|
2025 | 9.21% | 16.05% |
2026 | 9.43% | 2.39% |
2027 | 9.66% | 2.44% |
2028 | 10.33% | 6.94% |
2029 | 9.77% | 5.42% |
12 Brenntag Analysts have issued a net profit forecast 2025. The average Brenntag net profit estimate is €660m . This is 23.28% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €876m 63.61% , the lowest is €535m 0.08% .
This results in the following potential growth metrics and future Net Margins:
2024 | €536m | 21.56% |
---|---|---|
2025 | €660m | 23.28% |
2026 | €746m | 13.02% |
2027 | €818m | 9.60% |
2028 | €954m | 16.68% |
2024 | 3.30% | 18.77% |
---|---|---|
2025 | 3.87% | 17.30% |
2026 | 4.20% | 8.53% |
2027 | 4.45% | 5.95% |
2028 | 5.38% | 20.90% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 3.71 | 4.57 |
21.56% | 23.18% | |
P/E | 13.50 | |
EV/Sales | 0.68 |
12 Analysts have issued a Brenntag forecast for earnings per share. The average Brenntag EPS is €4.57 . This is 23.18% higher than earnings per share in the financial year 2024. The highest EPS forecast is €6.07 63.61% , the lowest is €3.71 0.00% .
This results in the following potential growth metrics and future valuations:
2024 | €3.71 | 21.56% |
---|---|---|
2025 | €4.57 | 23.18% |
2026 | €5.17 | 13.13% |
2027 | €5.66 | 9.48% |
2028 | €6.61 | 16.78% |
Current | 16.63 | 0.24% |
---|---|---|
2025 | 13.50 | 18.82% |
2026 | 11.95 | 11.48% |
2027 | 10.90 | 8.79% |
2028 | 9.34 | 14.31% |
Based on analysts' sales estimates for 2025, the Brenntag stock is valued at an EV/Sales of 0.68 and an P/S ratio of 0.52 .
This results in the following potential growth metrics and future valuations:
Current | 0.71 | 7.79% |
---|---|---|
2025 | 0.68 | 4.45% |
2026 | 0.65 | 3.98% |
2027 | 0.63 | 3.44% |
2028 | 0.65 | 3.64% |
2029 | 0.59 | 8.84% |
Current | 0.55 | 14.88% |
---|---|---|
2025 | 0.52 | 4.75% |
2026 | 0.50 | 4.00% |
2027 | 0.49 | 3.42% |
2028 | 0.50 | 3.63% |
2029 | 0.46 | 8.83% |
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Hold
➜
Buy
|
Upgrade | Jan 03 2025 |
MWB RESEARCH AG |
Buy
➜
Buy
|
Unchanged | Dec 18 2024 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Nov 25 2024 |
BERENBERG |
Hold
➜
Buy
|
Upgrade | Nov 25 2024 |
HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | Nov 19 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Nov 18 2024 |
Analyst Rating | Date |
---|---|
Upgrade
METZLER EQUITIES:
Hold
➜
Buy
|
Jan 03 2025 |
Unchanged
MWB RESEARCH AG:
Buy
➜
Buy
|
Dec 18 2024 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Nov 25 2024 |
Upgrade
BERENBERG:
Hold
➜
Buy
|
Nov 25 2024 |
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
Nov 19 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Nov 18 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.